SCHEMBL3852931

SCHEMBL3852931

O=C(Nc1ccc(F)cn1)c1ccc(Br)cc1Cl

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 7/20 0.60
RAB9A P51151 7/20 0.60
SMN1; SMN2 Q16637 4/20 0.60
MAPT P10636 2/20 0.60
MAPK1 P28482 2/20 0.60
SORT1 Q99523 3/20 0.58
KMT2A Q03164 3/20 0.48
ALDH1A1 P00352 1/20 0.48
LMNA P02545 1/20 0.48
GAA P10253 1/20 0.48
TP53 P04637 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
MEN1 O00255 2/20 0.47
RXFP1 Q9HBX9 1/20 0.47
AHR P35869 1/20 0.46
GRM5 P41594 2/20 0.46
FLT1 P17948 1/20 0.46
FLT4 P35916 1/20 0.46
KDR P35968 1/20 0.46
F10 P00742 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3851843 0.86 NPC1 (0.57) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL3850184 0.79 SORT1 (0.73) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL5234277 0.78 PYGL (0.55) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL5238444 0.78 NPC1 (0.52) NPC1RAB9ASMN1; SMN2MAPTMAPK1
SCHEMBL20177030 0.77 KDM4E (0.64) NPC1RAB9ASMN1; SMN2KMT2ALMNA
SCHEMBL29236199 0.77 AHR (0.47) NPC1RAB9ASMN1; SMN2MAPK1SORT1
SCHEMBL31027174 0.77 AHR (0.47) NPC1RAB9ASMN1; SMN2MAPK1SORT1
SCHEMBL31027173 0.77 AHR (0.47) NPC1RAB9ASMN1; SMN2MAPK1SORT1
SCHEMBL30761102 0.77 GRM5 (0.53) NPC1RAB9ASMN1; SMN2ALDH1A1TDP1
SCHEMBL18145934 0.76 NPC1 (0.53) NPC1RAB9ASMN1; SMN2KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed